Patents expiring in 2027

US 7311921

Multi-subtype FIV vaccines

The Regents of the University of California · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7311911

Methods for inhibiting angiogenesis

The Regents of the University of California · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7311916

Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312226

Substituted tricyclic compounds as protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312198

Protein compositions for promoting wound healing and skin regeneration

Essential Skincare, LLC · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312228

Cytotoxic indeno and isoindoloisoquinolones

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7312301

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

Nektar Therapeutics AL, Corporation · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2007147454

SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE

A C O M ADVANCED CT ONCOLOGY M [IT] · Granted Thu Dec 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314754

Polynucleotide encoding the hOT7T175 G protein coupled receptor

Takeda Pharmaceutical Company Limited · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314917

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314885

Pyrrole compounds useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314624

Nanoemulsion vaccines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314625

Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences

The United States as represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314956

Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell

Vaxim, Inc. · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314887

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314615

IκB Kinase-β (IKKβ) binding antibodies and methods of using same

The Regents of the University of California · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314858

Retrocyclins: antiviral and antimicrobial peptides

The Regents of the University of California · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314618

Antibodies to fibroblast growth factor (FGF23)

Ludwig-Maximilians-Universitat Munchen · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314911

Prostate hyperplasia therapy

The Board of Regents of the University of Texas System · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314731

Method for selecting therapeutic agents for cancer

Precision Therapeutics, Inc. · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7314632

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2653382

COMPOSITION STABILISEE COMPRENANT DES INHIBITEURS DE L'ECA

ALPHAPHARM PTY LTD [AU] · Granted Thu Jan 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)